| Compound |
Company |
Primary Therapeutical Area / Indication |
Drug development |
|
| Tacrolimus |
|
Immune System Diseases / Dermatitis, Atopic |
Phase IV
|
 |
|
|
| LCP-Tacro™ |
Veloxis Pharmaceuticals A/S
|
Immune System Diseases / Kidney Transplantation |
Phase III
|
 |
|
|
| Laquinimod |
|
Immune System Diseases / Multiple Sclerosis |
Phase III
|
 |
|
|
| SLITone(TM) Birch |
|
Immune System Diseases / Rhinitis, Allergic, Seasonal |
Phase III
|
 |
|
|
| Anti-NKG2D |
|
Immune System Diseases / Arthritis, Rheumatoid |
Phase II
|
 |
|
|
| DPK-060 |
|
Immune System Diseases / Dermatitis, Atopic |
Phase II
|
 |
|
|
| IBsolvMIR® |
|
Immune System Diseases / Diabetes Mellitus, Type 1 |
Phase II
|
 |
|
|
| Paquinimod (57-57) |
|
Immune System Diseases / Systemic Sclerosis |
Phase II
|
 |
|
|
| RhuDex |
|
Immune System Diseases / Arthritis, Rheumatoid |
Phase II
|
 |
|
|
| US SLIT Cat Hair |
|
Immune System Diseases / Rhinitis, Allergic, Perennial |
Phase II
|
 |
|
|
| Anti-C5aR |
|
Immune System Diseases / Arthritis, Rheumatoid |
Phase I
|
 |
|
|
| Anti-IL21 |
|
Immune System Diseases / Arthritis, Rheumatoid |
Phase I
|
 |
|
|
| Ragweed Tablet |
|
Immune System Diseases / Rhinitis, Allergic, Seasonal |
Phase I
|
 |
|
|
| EndoS |
|
Immune System Diseases / Lupus Erythematosus, Systemic |
Pre-clinical
|
 |
|
|
| FP219 |
|
Immune System Diseases |
Pre-clinical
|
 |
|
|
| FP237 |
|
Immune System Diseases |
Pre-clinical
|
 |
|
|
| FP289 |
|
Immune System Diseases |
Pre-clinical
|
 |
|
|
| IdeS |
|
Immune System Diseases / Graft vs Host Disease |
Pre-clinical
|
 |
|
|
| NZ39000 |
|
Immune System Diseases / Autoimmune Diseases |
Pre-clinical
|
 |
|
|
| Ph8 |
Phlogo
|
Immune System Diseases / Arthritis, Rheumatoid |
Pre-clinical
|
 |
|
|